Sheba at Sixty
www.sheba.co.il
Home page | Hospital Map | ̣áøéú | RU
Home page > Sheba HospitalsThe Acute Care HospitalDivision of Internal MedicineThe Ella Institute for Treatment and Research of Melanoma and Skin Cancer > What is Melanoma?
The Acute Care Hospital
The Rehabilitation Hospital
The Edmond and Lily Safra Children's Hospital
Division of Internal Medicine
Division of Surgery
The Joseph Buchman Gynecology and Maternity Center
The Division of Diagnostic Imaging
Laboratory Division
Department of Internal Medicine A
Department of Internal Medicine B and Research Center for Autoimmune Diseases
Department of Internal Medicine C
Department of Internal Medicine D & Hypertension Unit
Department Of Internal Medicine E
Department of Internal Medicine F
SCRC- The Sheba Cancer Research Center
Institute of Oncology
The Ella Institute for Treatment and Research of Melanoma and Skin Cancer
Radiation Oncology Department
The Institute of Hematology
The Bone Marrow Transplantation Department
Cord Blood Bank
The Israel National Hemophilia Center
The Amalia Biron Research Institute of Thrombosis and Hemostasis
Heart Institute
The Institute of Gastroenterolgy and Liver Diseases
Institute of Nephrology and Hypertension
Travel and Tropical Medicine Center
The Institute of Endocrinology
The Institute of Pulmonology, Physiology and Exercise
Bert W. Strassburger Lipid Center
The Allergy and Clinical Immunology Unit
Department of Dermatology
The Department of Neurology
The Department of Emergency Medicine
What is Melanoma?
Treatment of Melanoma
The Institute’s Laboratories
Clinical Research
Translational Research
Institute Staff
Publications by the Institute’s Staff Members
Links to Information Websites
The Department of General Surgery (Surgery B)
Department of Surgical Oncology (Surgery C)
The Department of Vascular Surgery
Department of Cardiac Surgery
Department of Orthopedics
The Department of Neurosurgery
Department of Thoracic Surgery
Department of Urology
The Goldschleger Eye Institute
Department of Otolaryngology - Head and Neck Surgery
The Department of Plastic & Reconstructive Surgery
Department of Oral and Maxillofacial Surgery
Department of Ambulatory Surgery
Hospital Dentistry Unit
Department of Anesthesiology and Intensive Care
General Intensive Care Unit
The Advanced Technology Center
Gynecology & Gynecology Oncology Department
Maternal Fetal Medicine Service
IVF Fertility Clinic
The Danek Gertner Institute of Human Genetics
Reproductive Endocrinology and Infertility
The OB/GYN Ultrasonic Imaging Unit
The Cardiovascular Imaging service : Cardiac MRI & Cardiac CT
Pediatric Imaging Unit
Neuro-interventional service
Interventional Radiology Section
Oncological Imaging and Cross-Sectional Imaging Section
The Musculoskeletal Imaging Unit
Ultrasound Unit
Diagnostic Neuro-radiology service
Uroradiology Unit
Department of Nuclear Medicine
Stat Laboratory
The Institute of Chemical Pathology
The Hematology Laboratory
The Abraham Rochlin Bacteriology Laboratory
The Endocrine Laboratory
Institute of Clinical Pharmacology and Toxicology
The Laboratory for Tissue Typing
Israeli Tissue Bank
The Blood Bank and Transfusion Center
Ziering newborn screening center
Institute of Pathology
Department of Orthopedic Rehabilitation
Department of Neurological Rehabilitation
Day Rehabilitation Unit
The Neuro-Oncology Day Hospital Rehabilitation Service
Pain RehabilItation
The Department of Respiratory Care and Rehabilitation
Geriatric Division
The Psychiatric Division
Multiple Sclerosis Center
The Institute for Fatigue and Sleep Medicine
The Cancer Hospice
HIV / AIDS Center
The Pediatric Emergency Department
General Pediatric Departments
The Department of Pediatric Surgery
The Pediatric Hemato - Oncology Department
The Department of Pediatric Intensive Care
Pediatric Rehabilitation Department
The Pediatric Psychosomatic Department
The Albert Katz Department of Neonatology
Pediatric Pulmonary Unit
Pediatric Neurology Institute
Pediatric Metabolic Disease Unit
Pediatric Gastroenterology Unit
The Department of Pediatric & Congenital Cardiothoracic Surgery
The Institute of Pediatric Cardiology
Pediatric Endocrinology & Diabetes Unit
Pediatric Nephrology Unit
The Pediatric Infectious Disease Unit
Child and Adolescent Psychiatry Unit
Weinberg Child Development Center
Pediatric Community Medicine Unit
Pediatric Stem Cell Research Institute
The Ella Institute for Treatment and Research of Melanoma and Skin Cancer
What is Melanoma?

Malignant melanoma is one of three major forms of skin cancer. Malignant melanoma develops from cells located primarily in the skin, called melanocytes. These cells produce the pigment melanin, which provides the skin with its typical brownish tone. A mole, or a ‘beauty spot', is an example of a cluster of normal melanocytes localized in one spot.

 

Malignant melanoma is a cancer which usually develops in the skin, but can also develop in other locations in the body which contain melanocytes, such as the eye or the mucous membranes.

 

Contrary to the other two common forms of skin cancer, basal cell carcinoma and squamous cell carcinoma, whereby excising the tumor actually heals the patient, the life expectancy after the excision of a melanoma lesion depends on the thickness of the growth, measured in millimeters. For instance, over 95% of the patients with superficial melanoma, less than 1 millimeter in thickness, are cured by a simple, appropriate surgical excision of the tumor. However, in patients with thicker melanomas, there is an actual risk for recurrence, which could reach 40%, if the thickness of the melanoma exceeds 4 millimeters. This is because thicker melanomas have already spread by the time of diagnosis, yet the centers of spread are microscopic and are not detectable by the currently existing imaging methodologies. One way to assess whether a melanoma has already metastasized is to biopsy the regional lymph nodes which drain the region of the melanoma, and examine the tissue under the microscope. This procedure is known as a biopsy of the ‘Sentinel Nodes'.     

 

It is important to point out that the majority of patients with skin melanoma are cured by the surgery. Hence the importance of monitoring and early detection in the primary stages of any suspicious mole. Only a minority of the patients will suffer a recurrence of the disease over time. Such a recurrence requires advanced and complex treatment modalities, aimed at reinforcing the patient's immune system.

 

 

Risk Factors

 

Which populations are at risk, and what are the significant risk factors for developing melanoma?

 

Several risk factors are known, most prominent of which are:

·        Many moles, and in particular, a-typical moles.

·        Personal or family history of melanoma.

·        Pigment afflictions from birth.

·        Light skin, light or red hair.

·        Extensive sun burns (particularly during childhood) and intense exposure to sun radiation (particularly intermittent exposure).

 

Melanoma is, therefore, a malignant growth of the skin. The reasons for the development of melanoma are diverse, and focus on two primary causes: 

Environmental causes - sun radiation, and genetic causes - skin structure, existence of multiple pigment afflictions, etc. These two primary causes ultimately diverge and cause genetic changes (mutations) in the melanocytes, which enable the malignant transformation to melanoma.

 

As in all other malignancies, the best and most efficient way to combat melanoma is by prevention, by means of handling the most prominent risk factors:  by education and monitoring of populations found at high risk to develop melanoma, and by avoiding excessive exposure to sun radiation.

When outside, it is recommend to cover the body as thoroughly as possible, wearing long pants and long-sleeved shirts, preferably from tightly woven fabrics. It is recommended to wear a broad-rimmed hat and sunglasses which filter the passage of the sun's rays. Sun screens with a Sun Protection Factor (SPF) exceeding 15 should be applied to all exposed areas. Staying outside or at the beach between 9 AM and 5 PM should be avoided.

Application of a sun screen intended for tanning is dangerous, and could increase the risk for melanoma, since it prolongs the exposure to the sun. Epidemiological studies in Europe demonstrated that exposure to the sun for tanning was longer, as the SPF of the sun screen was higher.  


Early Detection

 

As early as possible diagnosis of melanoma provides the highest chance for a complete cure.

 

As stated before, most patients with superficial melanoma less than 1 millimeter in thickness are completely cured by a simple surgical excision of the tumor. However, when melanoma is diagnosed at an advanced stage, when it is thick, there is a risk of spreading and the development of a metastatic disease, which is most dangerous and could be lethal. These reasons illustrate the great importance of early detection.

 

Early detection of melanoma can be achieved by educating the population to be aware of early signs of melanoma development, and by a professional monitoring, especially of high risk populations.

 

The clinical signs of the development of malignant skin melanoma include:

·        Appearance of a new pigment affliction on a skin area which was previously normal.

·        Changes of an existing mole (usually minor changes), according to the ABCD rule, which include:

Asymmetric shape

Changes in the Borders

Changes of the Color and tone

Changes in the Diameter

 

 

Next

Terms of Use  |  Contact Us  |  Other Sheba Sites